Research

Mayo Clinic researchers are working to improve diagnosis and treatment of progressive supranuclear palsy. Specialists trained in movement disorders conduct clinical trials and study research in genetics, molecular mechanisms, pathology, and diagnosis and treatment options for progressive supranuclear palsy.

Read more about research in Mayo Clinic's Parkinson's Disease and Clinical Genetics laboratory and in the Movement Disorders laboratory.

Publications

See a list of publications on progressive supranuclear palsy by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Research Profiles

Narrow Your Search

April 13, 2017
References
  1. Factor SA. Progressive supranuclear palsy (PSP).http://www.uptodate.com/home. Accessed Nov. 22, 2016.
  2. Progressive supranuclear palsy fact sheet. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/psp/detail_psp.htm. Accessed Nov. 22, 2016.
  3. Progressive supranuclear palsy. The Association for Frontotemporal Degeneration. https://www.theaftd.org/understandingftd/disorders/psp. Accessed Nov. 22, 2016.
  4. Colosimo C, et al. Fifty years of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry. 2014;85:938.
  5. Kim JH, et al. Communication impairments in people with progressive supranuclear palsy: A tutorial. Journal of Communication Disorders. 2015;56:76.
  6. Ferri FF. Progressive supranuclear palsy. In: Ferri's Clinical Advisor 2017. Philadelphia, Pa.: Elsevier; 2017. https://www.clinicalkey.com. Accessed Nov. 22, 2016.
  7. Fukui Y, et al. Differentiating progressive supranuclear palsy from Parkinson's disease by MRI-based dynamic cerebrospinal fluid flow. Journal of the Neurological Sciences. 2015;357:178.
  8. Rusz J, et al. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Journal of Neurology. 2015;262:992.
  9. AskMayoExpert. Parkinson disease: Physical medicine and rehabilitation. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
  10. A guide for people living with PSP, CBD, and other atypical Parkinsonian disorders. CurePSP. http://www.psp.org . Accessed Nov. 22, 2016.
  11. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Oct. 27, 2016.
  12. Owens E, et al. Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy. Parkinsonism and Related Disorders. 2016;28:107.
  13. Whitwell JL, et al. [18F]AV-1451 Tau positron emission tomography in progressive supranuclear palsy. Movement Disorders. In press. Accessed Nov. 26, 2016.
  14. Josephs KA. Key emerging issues in progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology. 2015;262:783.